Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bio, you said this:
"I believe 1 year behind for generic launch, with Icosapent Ethyl COGS is far too long to recover and compete with TEVA.
For the above speculations....I expect the defendants to settle very soon in generic case."
I ask this, why don't you believe JT when he says that he's pricing Vascepa so that there is no money to be made for TEVA and it's generic EPA? JT has come right out and said, the manufacturing process isn't easy or cheap. It wasn't that long ago when AMRN had four suppliers, then made a business decision and went with the lower cost company.
Can't wait for Sam's updates, we're doing fine.
At what cost to the patient do you push his LDL's under 70, do you look to see what his HDL's are? Total cholesterol? I kind of like my Primary looking at the large picture, plus I review my own lipids before seeing my Primary. I have hemochromatosis, as well as a wife that is a practitioner (NICU) she wouldn't write me a scrip for penicillin when we first married, nor anything else since. I nearly died from the battle of meatheads. I'm your wife, not your doctor bs. Different story, but back to cardiologists, I like my primary care doc, I like that he wrote Vascepa for me with minor coaching on my part, I like that he knows and cares about my liver.
I also like that he respects my fear of statins. Lastly, as an investor in Amarin, I hope my next blood work shows an increase in my HDL's and the hell with your statins and your LDL's. Do I think he'll write more scripts of Vascepa if my HDL's do improve, who knows. JV was right, he mentioned that primary's would have to look up how to write the order, with my wife's help, JV's and another doc with his DAW1 suggestion, I had the job done for him, my doc didn't have to do any thinking, but that doesn't mean that Primary's can't think and they are a valuable source for Amarin to be targeting.
Cardiolo, I like your posts, a lot too; but I think you're aware that fellow docs think that many cardiologists have that god complex going and you're taking it out on them a bit much.
JV, my DES have not improved YET, but I'm still less then a month on V. I've stopped taking Xidra after four months, I find that drug to be worthless, and with side effects.
The bottom link is about statins and your liver, if anyone cares.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848423/
Well, JL, we're not related. We have different Grannies. You're would have said,"So you are spending 25-50 million dollars for extra pills..because you don't trust your guidance?"
Mine would have said, "We're spending 25-50 million dollars for extra pills for there is an excellent chance insurance companies will demand that the FDA speeds up the label expansion for Vascepa. Vascepa not only saves lives, it saves us money in the long run."
Once management stops selling, we'll move up.
I can't blame them, but.....................
Thanks, January 20th will be one month on V, I'll post on what's going on on that date. My eyes don't tear, they weep in this northeast winter weather, so I'll know.
TO ANYONE,
How long does it take for V to help with DES? I take Xiidra (lifitegrast ophthalmic solution 5%) and it's not helping one damn bit, plus my insurance also doesn't cover this drug and it's cost is $452.00 a month.
At current share price, a lot of old longs would rather GIA then sell at anything close to current levels. Folks thinking that BP will see the big picture and offer billions while the market cap is at current levels are crazy.
Furthermore, once Amarin gets label expansion, TV adds will sell V, current issues are insurance coverage and label expansion, which can't come soon enough.
FDA needs to get onboard that folks are dying, and have been since 2013.
STS, I've been looking to see if others answered you. Like Jerry, my numbers are also different. I also called Amarin about two hours after I bought my Vascepa, they asked my last name and birth date. I offered to supply her with the number on my card, she said lets see how I can do with your name and birth date. She knew that I had bought at CVS, as well as how much I had paid.
As I have said in another post, I'm still believing that I'll get my insurance company to cover the drug. Time will tell.
JL, my wife actually works for a Practice (HV Newborn Physicians Group) that contracts out to the hospital, in the twenty years she has worked for "the hospital" it has evolved into a horrible mess where no one knows what the hell is happening, hospital management has made three distinct changeovers. Some good changes, then there are others. It's such a mess, that my wife knew she'd be asked who she worked for in a deposition, the Director of her Practice couldn't even tell her how to honestly answer the question.
Furthermore, I agree with you about contacting the FDA if I do not get reimbursed for the Vascepa that I bought today. My wife feels that I'd be better served if I called the number on the back of our insurance card and see what they have to say.
I also have hemochromatosis which should add a bit to any reasonable persons thinking. I'll keep you posted. I plan on trying to schedule a personal appointment with the claims department; if I do, I'll leave with them the results of the R-I study. I had also left one with my primary doctor, he knew about AMRN the stock, didn't buy at 3 bucks, but did look at the company. He's no fool, due to HH, I have a standing order for CBC, ferritin, iron, TIBC, he wrote another order (3/1/19) for my Lipid profile so he can see what Vascepa is doing. I'm borderline on cholesterol and not on statins, partly due to HH, I do not need any elevations in liver biochemistries which statins cause.
Off hand, I think I'll get my wife's insurance to pay, even if I don't, I kind of like a good bitch from time to time.
You also predicted that Docs are lazy and would like to have Vascepa's prescription information handy, which mine wanted and I had with me. I also added DAW 1, my doc had zero problem writing the order for me. That was the easy part.
My insurance is from my wife, the hospital that my wife works for is owned by an insurance company, plus, we can only go to CVS for all our medication. Antitrust laws, anyone?
Today, upon going to CVS for pick up, I was instructed that Vascepa was refused by my insurance company. I also know and like my Pharmacist. He has helped me with the runaround I got trying to get Nexium. I showed my Pharmacist my Vascepa coupon, he told me that it will only reimburses for a small percentage of the cost, I slugged my shoulders and asked him to go ahead and fill the scrip.
I paid $629.25 for 90 days, with a little note that CVS applied a manufacturer coupon for a savings of $326.74.
I also called Amarin to ask their opinion of this charge, they were able to see that I paid $629.25 and had no clue as to why CVS went past the $240.00 that they will be reimbursing to them.
As pointed out by you and others, Amarin has their work cut out getting insurance companies to pay for Vascepa, not a generic knock off.
Bourbon, that's what is in the egg nog
Fish, I hope you are right and so does my wife, she's not going to like hearing about any damn margin call! Bought another 1000 at 14.71, add today's drop to 4000 new shares and bingo, I'm in trouble.
IBB is down 1%
AMRN is down 6%
".But we do need volume..."
I bought 2,000 shares yesterday at 15.90 and another 1,000 today at 15.21, we need a word from our leader and his bankers. I'm bleeding real blood.
It is way way past when Amarin and their bankers needed to step up and support our SP, rather the CEO sells shares at a high and laughs at long time holders that foolishly bought when he sold, then are buying more for they believed!
He needs to start feeling Tasty's and my pain, and help clean up the puke.
Better chance that someone may know about AMRN getting into the Russell, when do they reline?
"Just like the secondary offering that was over prescribed within an hour. They know too"
Well my good man, those boys over paid. AMRN is on a fire sale right now, and it has been since the secondary offering.
"The smallish size of the sales force is a big tell to me . If AMRN had 100 % decided to GIA , that sales force would be larger"
Not a tell for me, there's a bit of training involved, plus cost. Not every doc is going to write off label, why pay reps to argue with someone that simply will not change their mind.
Lastly, no one knows the thinking of the BB or JT, they may be perfectly happy waiting for label expansion. This is a new game for most of us, JT, too. The BBoys have been around the block before, it's hard to imagine they aren't involved with this decision.
I'm more concerned about JV thinking about selling his shares. What's with that?
bfost, good post, I'm going to take a bit different route, but I like yours, too.
First off, I have a long standing relationship with my doctor, so he's also a bit of a friend. Furthermore, I've told him to learn about Amarin when it was a 3 buck stock, he may have or he may not have, I don't socialize with him. I'll find out 12/20. My wife is also his patient, she is a fellow doc, she won't write for me, "I'm your wife, not your doctor" baa, baa, baa 35+ years, never got quadludes :(
I've copied Bhatt's recent article, it's short and sweet. I wrote the order on top of the article looking like proof as to why I'm going to get it, Vascepa Caps 1 Gram qid 120/month 90days x4
I have a great degree of certainty that he'll write it for me. I'll point out that their is no down side. I also have enrolled with Amarin's so I have their coupon: Pay as little as $9. That's coming with me, too. That will eliminates any suggestion about o/c fish oil pills.
Lastly, if he won't write it, I'll tell him I want this script badly enough that I'll shop for another doctor who will write it, yet I can't see it coming down to that. Will know soon.
I think our new web site should have an investor's section, perhaps this could be added:
Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Amarin (AMRN) today and set a price target of $35. The company’s shares closed yesterday at $17.99.
Chen noted:
“We think the peak sales potential of Vascepa is underappreciated. Therefore, upward earnings revisions to levels not reflected in FactSet consensus expectations should drive AMRN shares higher. Valuation Summary We continue to use a blend of DCF and multiples (EV/EBITDA) analysis to get to our 12-month price target of $35.”
According to TipRanks.com, Chen is a 4-star analyst with an average return of 8.7% and a 37.9% success rate. Chen covers the Healthcare sector, focusing on stocks such as Bausch Health Companies Inc, Aridis Pharmaceuticals Inc, and Amneal Pharmaceuticals Inc.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Amarin with a $34.80 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $23.34 and a one-year low of $2.35. Currently, Amarin has an average volume of 18.37M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It’s product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale.
This was taken from Thero's little chat, I'm sure after touting how fast he raised the money, those same bankers he refereed to made some calls about the huge hit we took, this explains today's upside. IMO
So, recently, we did raise $200 million that was added to roughly $81 million that we began the quarter with. And we believe that, with those funds, it provides Amarin with a runway under most scenarios to get to cash flow positivity. So, we appreciate the support from investors in that financing.
It was a relatively small deal, given our market cap. I'm told by the bankers that it was oversubscribed in about an hour. So, glad that that was done.
And the topic of – sort of interesting to me that the topic of financing had become such a pervasive topic where it felt as though, well, whether we needed to finance right then or we could have waited just addressing the financing overhang and getting it behind us made sense.
Hopefully, now the focus will remain with the value of this drug, its importance towards potentially helping millions of patients, our launch of the drug here based upon the sort of data we have today and then the launch of it after we get label expansion post sNDA approval.
Do you know that he bought the puts? Could he have sold them? Buy stock, buy calls, sell puts pretty sure it's north of 21.00
There is no offer on the table, management has been very shareholder friendly, plus it's illegal not to tell us.
Form 8-K is a very broad form used to notify investors in United States public companies of specified events that may be important to shareholders
BB, I'm sorry about my comment, I didn't see this post:
When there's journalist that don't care about contributing to 900,000 deaths...it's damn hard to celebrate anything.--BB
"I don't think Amarin should submit a new drug application to the FDA...ever again.---BB"
Nor do I, they fought this fight "Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the people peaceably to assemble, and to petition the Government for a redress of grievances"
BB, as much as I want to agree with DollarBill, I hope you don't have peace, you're right; nearly a million deaths due to the FDA.
Subtract the damn 5%, RI-T results would still be stellar, who wants to die? Worse yet, have a stroke!
"kick Adam f in the nuts!"
It was the FDA that charged the panel with stating that they KNEW that lowering your Tgs would reduce MACE, the FDA needs the kick, Adam got it right.
I listened to Adam narrate that meeting with my wife whose's in the medical business, she told me that no way will this panel state the they KNEW, it was the FDA's wording-it's this wording that upsets our BB. Actually, my wife was surprised that two docs signed off on it.
Have you forgotten about Amarin's victory about their first amendment rights? Did you not hear JT tell you to listen closely to the Secondary endpoints? I know someone with diabetes that is taking four grams a day, soon the world will know.
BB, not only is this very, very low volume today trading is extremely bullish going into the AHA binary, like it or not, there's another binary coming, it's called BP.
JL, I'm more interested in hearing what the facilitator has to say in his three minutes of fame after Dr. Blatt speaks, I've seen these guys do a great deal of harm, plus, Dr. Blatt is not a screamer and I'd bet my bottom dollar that the facilitator will be. I do not remember his name, but I did look him up, he's a DHA guy.
JL,we can meet supply
It's my opinion that this BaaBaa chap as well as Hamkypanky are on this board to shed doubt as to the value of AMRN. Furthermore, I share your concern about supply, however, only to a degree.
The FDA killed the Sardine Industry in the USA, Amarin can meet supply, they have the know how. Check out this site:
https://bangordailynews.com/2010/04/14/news/nations-last-sardine-cannery-closing/
I'll tell you what his problem is, his college roommate one upped him. I'm very upset about this cat myself, plus I've never meet either one of these guys.
JL, thanks for the info and fun over the years, congrats to you and most of the longs on this board. Some folks have taken this all to serious over the years, I honestly couldn't believe the name calling that occurred later on in the study. Not that I think I was missed, but I stopped dropping in.
That said, I'm hoping that some guiding light (probably JL) is telling everyone that the party is just starting, everyone should be waiting until the Medical Convention, that's where the money is.
What we have here is: hearsay. We haven't heard a think about secondary endpoints. They will be HUGE. The Street likes facts, they are coming. The ride is just coming, enjoy
I never understood why AMRN when to the market in January with it's Equity Offering, but with today's prices, management looks pretty good picking up that 80 million when it did, meanwhile, I've lost a bundle since then, as has everyone else.
I highly doubt that Amarin has run a RWE study; however, I find it hard to believe that they haven't listened to what their sales force have reported back from over the years. RX's climbs over the years, aren't you thinking off label use?
Also, I find it hard to believe that the Baker Brothers haven't run a RWE study, they aren't in the business that knowledge is power.
While I have your attention, would you please remind me if you had all your patients take Vascepa prior to surgery, is so, how long prior to the procedure, then again after? Thanks.
(Baker Bros. Advisors is based out of New York. Baker Bros. Advisors is a hedge fund with 1-10 clients and discretionary assets under management (AUM) of $15,644,897,144 (Form ADV from 2017-09-28). Their last reported 13F filing for Q4 2017 included $11,537,077,000 in managed 13F securities and a top 10 holdings concentration of 81.68%. Baker Bros-AMRN is their 12th largest holding)
JL, you should write your own damn book, but make sure you include your college roommate.
A lot of the shit you say is funnier than hell, but I also think it's meant to be..................plus, you have a very serious side, to boot.
"Well at least the Amarin public offering happened, before the market heads into a major correction"
That's true, but that back filling that BB always talks about dating back to 2013 may or may not be true, however, I bought after hours the night of the announcement @ $3.87, then since I know more than the market, I bought again at the open the following day ($3.74) while these weren't margin shares, they weren't keepers either.
I highly doubt I was the only damn fool, I'm just happy I didn't buy the Brooklyn Bridge that night when it was offered to me.
Cheers, if R-I doesn't cut the mustard, none of this will matter. Plus, management is going to play cheer leader in the upcoming earnings report.
" So you think " accumulation was going on ".
Great
Can I interest you in this deal I have for the Brooklyn Bridge"
Wednesday, Thursday and Friday, AMRN didn't move a bit, so yes, I think someone was controlling the share price, it's my opinion. It's also my opinion that the Brooklyn Bridge isn't what it was before the Barclay Center was build, so no, you can't interest me in it.
However, do you any interest in the Manhattan Bridge?
"I will take a stab at that. How about they already sold the shares to cover the buy. Just a thought"
I'm agreeing with you, I also think it looked like accumulation was going on, or the stock was held back due to selling, we'll see tomorrow; for if I'm right, tomorrow will be an up day.
Nor was it what I had wanted to hear at the time.